Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1541 of 5804
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThis trial that is investigating a medication called duvelisib in combination with docetaxel for the treatment of squamous cell carcinoma of the head and neck (SCCHN) that has returned or spread outside the head and neck area. The names of the study drugs involved in this study …
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New CMV vaccine enters first human tests – could prevent dangerous infections
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to assess the safety, reactogenicity and immune response of the candidate CMV recombinant protein subunit (CMVsu) vaccine consisting of a combination of glycoproteins B (gB) and pentamer antigens adjuvanted, regardless of baseline CMV sero-status. Thi…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 19, 2026 00:00 UTC
-
Can couples counseling cut drug use and HIV? new study tests video modules
Prevention OngoingThis study utilizes a randomized controlled trial design to evaluate the efficacy of two intervention components for couples HIV testing and counseling (CHTC): a communication skills training video and a substance use module. Participants are randomized in a full-factorial design…
Phase: NA • Sponsor: Hunter College of City University of New York • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
New hope for advanced cancers: ABBV-400 enters human trials
Disease control OngoingCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is given to adult participants to treat advanced solid tumors. ABBV-400 is an invest…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo therapy offers hope for lung cancer patients who stopped responding to initial treatment
Disease control OngoingThis is a phase II, non-comparative, randomized study assessing combination of Tedopi with docetaxel or with nivolumab in NSCLC patients failing after first- line chemoimmunotherapy. In this non-comparative study, the standard arm (arm C) will serve as a calibration arm. All NSCL…
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug shows promise against tough cancers
Disease control OngoingThe goal of this study is to see how effective the study drug, sacituzumab govitecan-hziy, is in participants with solid tumor.
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could two weeks of radiation be as good as six for this brain cancer?
Symptom relief Recruiting nowThis phase II trial studies the clinical outcomes of hypofractionated radiation therapy in patients with diffuse midline gliomas. This study aims to change the way radiation is delivered, from giving 6 weeks of radiation all at once to giving 2 weeks of radiation. This may determ…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Double antiviral attack: could two flu drugs beat one for vulnerable patients?
Disease control Recruiting nowThis phase II trial studies the effect of baloxavir in combination with oseltamivir in treating severe influenza infection in patients who have previously received a hematopoietic (blood) stem cell transplant or have a hematological malignancy. Baloxavir is an antiviral drug that…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Eye camera could spot Alzheimer's and Parkinson's early
Diagnosis Recruiting nowHyperspectral retinal imaging is a non-invasive imaging modality in which a series of images of the retina are captured using light of different wavelengths. The resulting "hypercube" of data provides a wealth of information about the retinal structure. Our group has developed ev…
Phase: NA • Sponsor: Center for Eye Research Australia • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Intensive therapy boosts skills in kids with brain injury
Disease control CompletedBy longitudinal, prospective research in children with neurodisabilities including severe motor impairments and their parents to explore the beneficial effects of participating in an intensive habilitation program on the child's adaptive functioning and parental empowerment in or…
Phase: NA • Sponsor: Sorlandet Hospital HF • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Sound waves for endometriosis: do the benefits last?
Disease control Recruiting nowEvaluate the long-term effects of HIFU treatment for rectal endometriosis.
Sponsor: EDAP TMS S.A. • Aim: Disease control
Last updated Jun 26, 2026 18:45 UTC
-
New lung valve registry aims to improve breathing in severe emphysema
Symptom relief Recruiting nowThis is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Sponsor: Olympus Corporation of the Americas • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail aims to boost remission in tough lymphoma
Disease control TerminatedThis phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Minutes, not days: new rapid test could speed up thyroid cancer detection
Diagnosis CompletedBackground: Despite a favorable prognosis, metastatic cervical lymph nodes (LN), are not uncommon among patients with differentiated thyroid cancer (DTC). Current guidelines recommend that a suspicious cervical LN on neck ultrasound (US) should be investigated with fine needle as…
Sponsor: Soroka University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Stroke survivors try high-tech treadmill training to stop falls
Symptom relief CompletedFollowing a stroke, many individuals have a high risk of falls, which can negatively influence quality of life. Unfortunately, current treatments have not effectively addressed this problem. This study investigates whether two methods of delivering mechanical perturbations during…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Eczema treatment FURESTEM-AD under Long-Term watch
Disease control OngoingLong-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study
Sponsor: Kang Stem Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Green tea extract tested to keep prostate cancer in check
Disease control OngoingThis phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Weekly HIV pill could replace daily doses
Disease control OngoingThe primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologically suppressed people with HIV (PWH) at Week 24.
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental CAR t therapy takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. * TriPRIL CAR T Cells * Fludar…
Phase: PHASE1 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New Antibody-Chemo combo targets tough lymphoma
Disease control OngoingThis is an open-label multicenter randomized non comparative phase II study to evaluate the safety and efficacy of the monoclonal anti-KIR3DL2 antibody Lacutamab in patients with Refractory/Relapsing (R/R) KIR3DL2 positive Peripheral T Cell Lymphoma (PTCL) : Not Other Specified (…
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC